NVS Competitors & Alternatives
Compare Novartis AG ADR with similar stocks in the same industry
Drug Manufacturers - General
NVS
Main Stock$158.86
Tradestie Score
50
Market Cap
$254.99B
P/E Ratio
23.6
Revenue Growth
0.0%
Analyst Upside
-1.1%
Top Competitors
17 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
JNJ
Johnson & Johnson
|
$270.24
|
$448.07B | 31.8 | 42 | Compare |
|
ABBV
ABBVIE INC.
|
$264.96
|
$431.71B | 75.2 | 41 | Compare |
|
NVO
Novo-Nordisk A/S
|
$46.74
|
$262.92B | 11.4 | 49 | Compare |
|
AZN
AstraZeneca PLC
|
$165.98
|
$261.56B | 24.7 | 68 | Compare |
|
MRK
Merck & Co., Inc.
|
$152.55
|
$225.13B | 122.1 | 45 | Compare |
|
AMGN
Amgen Inc
|
$439.33
|
$160.70B | 27.5 | 38 | Compare |
|
PFE
Pfizer Inc.
|
$28.07
|
$154.70B | 35.7 | 40 | Compare |
|
GILD
Gilead Sciences Inc
|
$146.12
|
$137.92B | - | 34 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$45.85
|
$121.27B | 23.4 | 34 | Compare |
|
BMY
Bristol-Myers Squibb Co.
|
$67.01
|
$96.54B | 14.4 | 37 | Compare |
More NVS Analysis
Data updated: Aug 23, 2026 | Industry: Drug Manufacturers - General (SIC 2834)
17 stocks in this industry